Related Experiment Video
Updated: Jul 10, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Evidence for persistent Chlamydia pneumoniae infection of human coronary atheromas
Nicole Borel1, James T Summersgill, Sanghamitra Mukhopadhyay
1Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 268, CH-8057 Zurich, Switzerland. n.borel@access.unizh.ch
Insights
Researchers visualized persistent Chlamydia pneumoniae bacteria in human atherosclerotic tissues. This study reveals aberrant bacterial bodies in coronary artery disease, offering new insights into atherosclerosis pathogenesis.
Area of Science:
- Microbiology
- Pathology
- Cardiovascular Research
Background:
- Chlamydia pneumoniae is an intracellular bacterium implicated in atherosclerosis.
- Persistent forms and specific developmental stages of C. pneumoniae in human atherosclerotic tissues remain poorly characterized.
- Understanding bacterial presence is crucial for elucidating disease mechanisms.
Purpose of the Study:
- To identify and characterize developmental stages of Chlamydia pneumoniae, particularly persistent forms, within human atherosclerotic tissues.
- To investigate the presence of aberrant bacterial bodies in vivo using advanced microscopy techniques.
- To confirm the chlamydial origin of observed structures.
Main Methods:
- Utilized transmission electron microscopy (TEM) combined with immunogold labeling.
- Employed antibodies specific for chlamydial heat shock proteins (GroEL, GroES) and chlamydial lipopolysaccharide (LPS)/MOMP.
- Examined archival coronary atheromatous heart tissues from patients.
Main Results:
- Identified intracellular, atypical, round to oval structures resembling chlamydial reticulate bodies within smooth muscle cells, macrophages, and fibroblasts.
- Demonstrated these structures were of chlamydial origin using double immunogold labeling.
- Confirmed the presence of aberrant bodies of C. pneumoniae in vivo in atherosclerotic tissues.
Conclusions:
- The study provides the first description of C. pneumoniae developmental stages in human atherosclerotic tissues.
- Aberrant bodies of C. pneumoniae are present in vivo within coronary atheromatous tissues.
- These findings contribute to understanding the role of C. pneumoniae in the pathogenesis of atherosclerosis.
Abstract:
To date, structures representing developmental stages of Chlamydia pneumoniae, especially persistent forms of this intracellular bacteria, have not been described in human atherosclerotic tissues using specific antibody labeling and transmission electron microscopy. Staining of atherosclerotic tissue from five patients seeking heart transplantation with gold-labeled antibodies specific for up-regulated chlamydial heat shock proteins, GroEL and GroES, and visualisation via transmission electron microscopy revealed intracellular, atypical, round to oval structures of variable diameter. These structures resembled reticulate bodies of Chlamydia, were surrounded by membranes and were located within smooth muscle cells, macrophages or fibroblasts. By using double immunogold electron microscopy technique (GroEL and GroES in combination with chlamydial LPS/MOMP antibodies), we demonstrated these structures were of chlamydial origin. In the current study, we demonstrated the presence of aberrant bodies of C. pneumoniae in vivo in archival coronary atheromatous heart tissues by the immunogold electron microscopy technique.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Bacterial Phylum Chlamydiae
